Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106105/1/acr22121.pd
Rahul G Argula,1 Celine Ward,2 Carol Feghali-Bostwick2 1Department of Medicine, Division of Pulmonar...
Background: Survival in patients with systemic sclerosis (SSc) associated pulmonary hypertension (PH...
Objectives: To describe the clinical phenotype and prognosis of people in the Australian Scleroderma...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a leading cause of mortality in systemic sclero...
AbstractBACKGROUND:Patients with pulmonary arterial hypertension (PAH) associated with systemic scle...
Objectives: To describe the survival rate in a cohort of systemic sclerosis (SSc) patients with pulm...
BACKGROUND: Patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis ...
BACKGROUND: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
Background: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with...
The prognostic importance of follow-up haemodynamics and the validity of multidimensional risk asses...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107488/1/art38623.pd
OBJECTIVE: Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc...
Pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) has been poo...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a major cause of morbidity and mortality in pat...
Rahul G Argula,1 Celine Ward,2 Carol Feghali-Bostwick2 1Department of Medicine, Division of Pulmonar...
Background: Survival in patients with systemic sclerosis (SSc) associated pulmonary hypertension (PH...
Objectives: To describe the clinical phenotype and prognosis of people in the Australian Scleroderma...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a leading cause of mortality in systemic sclero...
AbstractBACKGROUND:Patients with pulmonary arterial hypertension (PAH) associated with systemic scle...
Objectives: To describe the survival rate in a cohort of systemic sclerosis (SSc) patients with pulm...
BACKGROUND: Patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis ...
BACKGROUND: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
Background: In this study, we investigated the impact of the new haemodynamic definition of pulmonar...
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in patients with...
The prognostic importance of follow-up haemodynamics and the validity of multidimensional risk asses...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107488/1/art38623.pd
OBJECTIVE: Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc...
Pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) has been poo...
BACKGROUND: Pulmonary arterial hypertension (PAH) is a major cause of morbidity and mortality in pat...
Rahul G Argula,1 Celine Ward,2 Carol Feghali-Bostwick2 1Department of Medicine, Division of Pulmonar...
Background: Survival in patients with systemic sclerosis (SSc) associated pulmonary hypertension (PH...
Objectives: To describe the clinical phenotype and prognosis of people in the Australian Scleroderma...